CHRONIC URINARY TRACT INFECTION: ETIOLOGICAL AGENTS AND SUSCEPTIBILITY TESTING by Faris, Nawal S.
European Scientific Journal November 2015 edition vol.11, No.33 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
327 
CHRONIC URINARY TRACT INFECTION: 
ETIOLOGICAL AGENTS AND SUSCEPTIBILITY 
TESTING 
 
 
 
Dr. Nawal S. Faris 
Department of Allied Medical Sciences, Zarqa University, Jordan. 
 
 
Abstract 
 Chronic Urinary Tract Infections (UTIs) are infections of the urinary 
tract that do not respond to treatment. They may either continue to affect 
your urinary tract despite getting the right treatment, or may recur after the 
treatment process. Although UTIs can happen to anyone at any age, they are 
more prevalent in women. In fact, the National Kidney and Urologic 
Diseases Information Clearing House estimated that one out of five young 
adult women suffers from recurring UTI. Therefore, the aim of this study is 
to strengthen the surveys of the cases of Chronic Urinary Tract Infections 
(UTIs). In addition, we also aim to evaluate the etiological agents of the 
chronic urinary tract infections; and finally, the culture characterization and 
antibiotic susceptibility testing of the isolated pathogenic bacteria.  In order 
to achieve these goals, we carried out a survey of 406 patients that had 
chronic urinary tract infection. Also, these patients had urine sample in the 
Department of Microbiology at the Central Laboratory of the Ministry of 
Health in Amman, which is the capital of Jordan from January to September 
2014. Using the urine sample, culture and biochemical test and antisera were 
performed. A total of 406 urine samples were tested for bacterial infection. 
Thus, the most commonly isolated organism was Escherichia coli (70%). β -
Hemolytic Streptococcus group B (8%) and Klebsiella sp (7.6%) were 
reported as the next most common organisms. Of all the bacteria isolated 
from chronic infection, only 21% were sensitive to ampicillin, 23% to 
ciprofloxacin, and 18% to cotrimoxazole. The highest levels of susceptibility 
were observed in cephalothin (81%), Gentamicin (40 %), Augmentin (33%), 
Norfloxacin (28%), Nitrofurantion (23%), Lefloxacin (21%), Nalidixic acid 
(16%), and Imipenem (14%). Conclusion: Gram-negative agents are the 
most common cause of UTI. Cephalothin remains the choice among the 
orally administered antibiotics, which is followed by Gentamicin, 
Augmentin. For severe disease caused by Escherichia coli which is the most 
common causes of chronic UTI, it requires antibiotics such as nitrofurantion. 
This is followed by third generation cephalosporins, which were the most 
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effective.   
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Introduction 
 Chronic urinary tract infections are mostly common in women. This 
is due to two different aspects of basic human anatomy. Firstly, the urethra is 
close to the rectum in women. As a result, it is extremely easy for bacteria 
from the rectum to reach the urethra, particularly if you wipe back to front 
instead of front to back. This is why young girls often get UTIs because they 
have not yet mastered the art of wiping. Secondly, in women, the urethra is 
shorter than men. So bacteria have a shorter distance to travel to get to the 
bladder, where they can multiply and cause infection more readily. There are 
other lifestyle factors that can put you at extra risk of developing a chronic 
UTI [2]. For example, using a diaphragm during sex can cause problems. 
Diaphragms push up against the urethra, making it harder to fully empty 
your bladder. The urine which has not been emptied fully is more likely to 
grow bacteria. Another example is in constantly changing the bacterial 
makeup of the vagina. Consequently, if you use antibacterial vaginal 
douches, spermicides, and certain oral antibiotics regularly, you are basically 
changing your vaginal bacteria regularly. This can increase your risk of 
developing a chronic UTI [1]. Menopause can cause similar problems in 
some women. Menopause causes hormone changes that in turn can cause 
changes in your vaginal bacteria [5]. Thus, this can increase your risk of 
chronic UTIs. Diabetes mellitus, neurologic conditions, chronic institutional 
residence, and chronic indwelling urinary catheterization are important 
predisposing factors for complicated UTIs. In affected patients, organisms 
that are typically less virulent may cause marked illness. Nevertheless, E. 
coli infection remains the most common organism in nearly all patient 
groups. Klebsiella and group B streptococcus infections are relatively more 
common in patients with diabetes. Also, Pseudomonas infections are 
relatively more common in patients with chronic catheterization. Proteus 
mirabilis is a common uropathogen in patients with indwelling catheters, 
spinal cord injuries, or structural abnormalities of the urinary tract [4]. 
Symptoms of a UTI that is affecting your bladder include frequent bloody 
urination or dark urine, burning sensation while urinating, and pain in your 
kidneys (in your lower back or below the ribs).  If the UTI spreads to your 
kidneys, it might lead to nausea and vomiting, chills, fever, fatigue, and 
mental disorientation. UTIs are most commonly diagnosed through a lab test 
performed on a urine sample. A medical professional will examine the 
sample through a microscope, and will look to see if there are any bacteria in 
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the urine. In a urine culture test, a urine sample is placed in a tube to 
encourage the growth of bacteria [3]. Diagnostic evaluation in the setting of 
predisposing factors (i.e., complicated UTI) differs in that a urine culture 
including antibiotic sensitivities is almost always required to guide the 
therapy. Obtaining a serum chemistry panel and assessing the patient's 
general medical status (e.g., hydration, toxicity) are important. For older or 
immunocompromised patients and those who have congenital malformations 
of the kidney, CT or ultrasonography is usually required [6]. Consequently, 
the bacteria will be looked at to determine the best treatment measure. If 
your doctor suspects kidney damage, he or she may order X -rays and kidney 
scans. However, these are imaging devices that take pictures of parts of your 
body. If you do have recurring UTIs, your doctor may want to perform a 
cystoscopy. In this procedure, he or she will use a cytoscope—a long thin 
tube with a lens at the end—to look inside your urethra and bladder [3]. Your 
doctor will be looking for any abnormalities or issues that could be causing 
the UTI to keep coming back. UTIs are treated with antibiotics over the 
course of one week [1]. Antimicrobial prophylaxis has proved effective in 
reducing the risk of recurrent UTIs in women with two episodes of infection 
in the previous year. Continuous prophylaxis for six to 12 months reduces 
the rate of UTIs during the prophylaxis period, with no difference between 
the six-month and 12-month treatment groups after cessation of prophylaxis 
[7]. Prophylactic antibiotic selection should be made on the basis of 
community resistance patterns, side effects, and local costs. Also, various 
dosages of prophylactic antibiotics have been suggested. 
 
Methods 
 A fresh urine sample should be collected in a sterile container. Once 
it has been collected, the urine should be taken to the laboratory within half 
an hour after collection or should be transferred to the lab as soon as 
possible. Selective and differential plating media (EMB Eosin Methylene 
Blue or MacConky agar and blood agar), were incubated overnight (18-24 
hours) at 37C. The plates were then examined for numbers of colonies of 
significant bacteria. Pure colonies of gram negative bacteria should be 
screened with the biochemical test media which consists of triple sugar iron 
agar (TSI), lysine iron agar (LIA), motility-indol-ornithine agar (MIO), 
Simmons citrate agar, and Biochemical Screening (Use of TSI). Two isolated 
questionable pure colonies was selected and inoculated in TSI slants and 
butt. This was together with a sterile platinum inoculating needle.  The center 
of the colony was touched once. Then, the butt was stabbed, and the TSI 
slant was streaked. Without going back to the colony, it was incubated at 
approximately 36oC with their caps loose (to prevent excess H2S production) 
for 18-24 hours.  Consequently, TSI reactions were examined as a set. 
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Yellow is an acid reaction, while red or purple is an alkaline reaction in TSI 
Acid/acid (slant/butt). After 18-24 hours, TSI indicates either lactose, 
sucrose, or both been fermented. Non-lactose fermenters may utilize the 
0.1% glucose causing both the deep and the slant to be yellow. Biochemical 
identification can be completed using Biolog, bioMerieux API 20E strips, 
Enterotubes, or equivalent kits. Furthermore, the manufacturer's instructions 
for each kit should be followed closely. For gram positive bacteria, gram 
stain and catalase, coagulase, and streptix kit hemolytic characteristics 
should be done. Finally, the sensitivity to antibiotics of pathogenic bacteria 
which was isolated should be checked out. 
 
Results 
 Based on the biochemical and immuno-reactivity, 406 patients had 
chronic urinary tract infection  10 5 colony-forming units (CFU/mL). Also, 
they had their urine sampled in the Central Laboratory of the Ministry of 
Health in Amman, which is the capital of Jordan from January to September 
2014. Antimicrobial susceptibility testing was done by the disk diffusion 
method (Kirby-Bauer) & Antibiotic profile.  Statistical analysis was carried 
out using ANOVA.  
 Based on the results of the urine cultures of 409 patients that had 
chronic urinary tract infection, the prevalence of the chronic urinary tract 
infection in female is almost six times that of male (84% vs. 15%) (Table 1).  
Table 1.  The prevalence of male vs. female 
Months No of  female No of male 
January 30 5 
February 26 10 
March 25 7 
April 26 1 
May 30 3 
June 33 2 
July 34 5 
August 21 5 
September 35 8 
Total 260 46 
Percentage 84% 15% 
   
 The most commonly isolated organism was Escherichia coli (66%). 
β-Hemolytic Streptococcus group B  (9.8%) and Klebsiella sp (11.4%) were 
reported as the next most common organisms. Therefore, the other bacteria 
are summarized in Table 2. 
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Table 2. Micro-organism isolated in urine 
Agents Number (306) % 
E.coli 202 66 
Streptococcus group B 30 9.8 
Klebsiella sp 35 11.4 
Enterococcus sp 13 4.2 
proteus sp 7 2.3 
Pseudomonas sp 5 1.6 
Staphcoagulase  negative 8 2.6 
Enterobacter 6 2 
 
 The comparison of the susceptibility pattern of organisms to various 
antimicrobial agents from all the specimens was shown in Table 3. 
Escherichia coli showed high susceptibility to nitrofurantoin (85%). Then, 
this was followed by gentamicin (73%), cefotaxime fluoroquinolones (70%), 
Cotrimoxazole (54%), norfloxacin (50%), and ciprofloxacin (35%). Also, 
there was a low susceptibility pattern of E. coli to ampicillin (29%), and 
amikacin (4%).   
Table 3. Antibiotic susceptibility of uropathogens 
Antibiotics E.coli(%) Streptococcus group 
B(%) 
Klebsiella sp(%) 
Ampicillin 27 80 1 
Gentamicin 73 12 75 
Norfloxacin 50 1 60 
Nitrofurantion 85 19 64 
Nalidixic acid 33 3 52 
Cefotaxime 70 20 64 
Ciprofloxacin 35 0 23 
Amikacin 4 0 3 
Cotrimoxazole 54 1 55 
 
Discussion 
 Recurrent UTIs are common among healthy young women with 
anatomically and physiologically normal urinary tracts [11]. One study 
showed that of the college women with a first UTI, 27 percent had at least 
one culture confirmed recurrence within the following six months; also, 2.7 
percent experienced a second recurrence over the same period.[12] In a 
primary care setting, 53 percent of women older than 55 years and 36 percent 
of younger women, had a recurrence within one year.[13]. In our study, the 
prevalence of the chronic urinary tract infection in female is almost six times 
that of male (84% vs. 15%). Diabetes mellitus, neurologic conditions, 
chronic institutional residence, and chronic indwelling urinary 
catheterization are important predisposing factors for complicated UTIs. In 
affected patients, organisms that are typically less virulent may cause marked 
illness. Although E. coli infection remains the most common organism in 
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nearly all patient groups, Klebsiella and group B streptococcus infections are 
relatively more common in patients with diabetes. Also, Pseudomonas 
infections are relatively more common in patients with chronic 
catheterization. Proteus mirabilis is a common uropathogen in patients with 
indwelling catheters, spinal cord injuries, or structural abnormalities of the 
urinary tract. The most commonly isolated organism was Escherichia coli 
(66%), β-Hemolytic Streptococcus group B (9.8%), and Klebsiella sp 
(11.4%). However, this was reported as the next most common organisms. E. 
coli exhibited resistance to the commonly used antibiotics. Therefore, the 
most effective in-vitro agents were found to be aminoglycosides: 
nitrofurantion (85%) and gentamicin (73%) among the injectables, and 
fluoroquinolonas: norfloxacin (50%) and ciprofloxacin (35%). The 
organisms showed resistance to commonly used urinary antibiotics like 
ampicillin (27%) and amikacin (4%). Therefore, this is in disagreement with 
the data published by others [13,17,18].  In summary, nitrofurantion remains 
the choice among the orally administered antibiotics, followed by 
gentamicin. In treating severe illness, one may use the injectable antibiotics. 
Among them, we should choose aminoglycosides, which are the most 
effective ones. In addition, the high resistance patterns to ampicillin and 
amikacin should always be put into consideration.  
 
Conclusion   
 In conclusion, the most common community acquired UTI is caused 
by negative-Gram agents. Nitrofurantion remains the choice among the 
orally administered antibiotics, followed by gentamicin. For severe disease 
that requires parenteral antibiotics, the choice should be aminoglycosides. 
Thus, this is regarded to be the most effective method. 
 
Acknowledgements 
 I would like to express my sincere thanks and deepest gratitude and 
faithfulness to Zarqa University, for supporting my research. Also, I am 
deeply grateful to the authorities of  the Ministry of Health where the 
samples were collected for the study. 
 
References: 
Chronic Urinary Tract Infections. Baylor College of Medicine. Retrieved 
September 18, 2012 from http://www.baylorclinic.com/services-
specialties/obstetrics/conditions/chronic-urinary-tract-infections.cfm  
E. coli. (2012, July 28). Mayo Clinic. Retrieved September 18, 2012, from 
Recurrent urinary tract infections in women: diagnosis and management. 
(2010). American Academy of Family Physicians. Retrieved July 25, 2012, 
from http://www.aafp.org/afp/2010/0915/p638.html  
European Scientific Journal November 2015 edition vol.11, No.33 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
333 
Urinary tract infections: MedlinePlus. (n.d.). National Library of Medicine – 
National Institutes of Health. Retrieved July 25, 2012, from 
http://www.nlm.nih.gov/medlineplus/urinarytractinfections.html  
Ronald A. The etiology of urinary tract infection: traditional and emerging 
pathogens. Am J Med. 2002;113(suppl 1A):14S–19S. 
Perrotta C, et al. Oestrogens for preventing recurrent urinary tract infection 
in postmenopausal women. Cochrane Database Syst Rev. 
2008;(2):CD005131. 
Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am. 
2008;35(1):13–22 
Albert X, et al. Antibiotics for preventing recurrent urinary tract infection in 
non-pregnant women. Cochrane Database Syst Rev. 2004;(3): CD001209 
American College of Obstetricians and Gynecologists. ACOG Practice 
Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. 
Obstet Gynecol. 2008;111(3):785–794. 
rekonja DM, et al. Urinary tract infections. Prim Care. 2008;35(2):345–367. 
Perrotta C, et al. Oestrogens for preventing recurrent urinary tract infection 
in postmenopausal women. Cochrane Database Syst Rev. 
2008;(2):CD005131 
American College of Obstetricians and Gynecologists. ACOG Practice 
Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. 
Obstet Gynecol. 2008;111(3):785–794. 
Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J 
Public Health. 1990;80(3):331–333. 
Ikäheimo R, et al. Recurrence of urinary tract infection in a primary care 
setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 
1996;22(1):91–99 
 
 
  
